cyclo(leucylglycine) has been researched along with Substance Withdrawal Syndrome in 1 studies
cyclo(leucylglycine): RN given refers to cpd without isomeric designation
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhargava, HN | 1 |
1 other study available for cyclo(leucylglycine) and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Cyclo (leucylglycine) inhibits the development of morphine induced analgesic tolerance and dopamine receptor supersensitivity in rats.
Topics: Analgesia; Animals; Dipeptides; Drug Tolerance; Half-Life; Humans; Male; Morphine; Motor Activity; N | 1980 |